Joyce M. Zarling

Person

Seattle, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for inhibiting the production of HIV-1 retrovirus using mon...
- Patent number 6,384,198
- Issue date May 7, 2002
- Bristol-Myers Sqibb Company
- Michael L Diegel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies and FV specific for CD2 antigen
- Patent number 5,807,734
- Issue date Sep 15, 1998
- Bristol-Myers Squibb Company
- Michael L. Diegel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies and FV specific for CD2 antigen
- Patent number 5,795,572
- Issue date Aug 18, 1998
- Bristol-Myers Squibb Company
- Michael L. Diegel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oncostatin M and novel compositions having anti-neoplastic activity
- Patent number 5,618,715
- Issue date Apr 8, 1997
- Oncogen Limited Partnership
- Mohammed Shoyab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oncostatin M and novel compositions having anti-neoplastic activity
- Patent number 5,451,506
- Issue date Sep 19, 1995
- Oncogen Limited Partnership
- Mohammed Shoyab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oncostatin M and novel compositions having anti-neoplastic activity
- Patent number 5,428,012
- Issue date Jun 27, 1995
- Oncogen Limited Partnership
- Mohammed Shoyab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oncostatin M and novel compositions having anti-neoplastic activity
- Patent number 5,120,535
- Issue date Jun 9, 1992
- Oncogen
- Hans Marquardt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of adoptive immunotherapy for treatment of aids
- Patent number 5,081,029
- Issue date Jan 14, 1992
- Oncogen
- Joyce M. Zarling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Joyce M. Zarling

Person

Patents Grantslast 30 patents

Methods for inhibiting the production of HIV-1 retrovirus using mon...

Monoclonal antibodies and FV specific for CD2 antigen

Monoclonal antibodies and FV specific for CD2 antigen

Oncostatin M and novel compositions having anti-neoplastic activity

Oncostatin M and novel compositions having anti-neoplastic activity

Oncostatin M and novel compositions having anti-neoplastic activity

Oncostatin M and novel compositions having anti-neoplastic activity

Methods of adoptive immunotherapy for treatment of aids